2019 annual financial data
Keros Therapeutics 2019 Net margin
Direct answer
Net margin was -123.44%.
Operating income was -10,563,000 USD and net income was -12,344,000 USD.
Operating cash flow was -15,998,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -10,563,000 USD
- Net income
- -12,344,000 USD
- Operating cash flow
- -15,998,000 USD